Methods for Identifying Culprit Drugs in Cutaneous Drug Eruptions: A Scoping Review

1. Mockenhaupt, M . Epidemiology of cutaneous adverse drug reactions. Advers Cutan Drug Eruptions. 2017;1(1):96-108.doi:10.5414/ALX01508E
Google Scholar2. Demoly, P., Adkinson, NF., Brockow, K et al. International consensus on drug allergy. Allergy Eur J Allergy Clin Immunol. 2014;69(4):420-437.doi:10.1111/all.12350 24697291
Google Scholar | Crossref | Medline3. Théophile, H., André, M., Arimone, Y., Haramburu, F., Miremont-Salamé, G., Bégaud, B. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance. J Clin Epidemiol. 2012;65(10):1069-1077.doi:10.1016/j.jclinepi.2012.04.015 22910538
Google Scholar | Crossref | Medline4. Duong, TA., Valeyrie-Allanore, L., Wolkenstein, P., Chosidow, O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390(10106):1996-2011.doi:10.1016/S0140-6736(16)30378-6 28476287
Google Scholar | Crossref | Medline5. Théophile, H., Dutertre, J-P., Gérardin, M et al. Validation and reproducibility of the updated french causality assessment method: An evaluation by pharmacovigilance centres & pharmaceutical companies. Therapie. 2015;70(5):465-476.doi:10.2515/therapie/2015028 26423144
Google Scholar | Crossref | Medline6. Agbabiaka, TB., Savović, J., Ernst, E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21-37.doi:10.2165/00002018-200831010-00003 18095744
Google Scholar | Crossref | Medline7. Théophile, H., André, M., Miremont-Salamé, G., Arimone, Y., Bégaud, B. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference. Drug Saf. 2013;36(10):1033-1044.
Google Scholar | Crossref | Medline8. Khan, LM., Al-Harthi, SE., Osman, A-MM., Sattar, MAAA., Ali, AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016;24(4):485-493.doi:10.1016/j.jsps.2015.01.010 27330379
Google Scholar | Crossref | Medline9. Danan, G., Benichou, C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323-1330.doi:10.1016/0895-4356(93)90101-6 8229110
Google Scholar | Crossref | Medline10. Arimone, Y., Bégaud, B., Miremont-Salamé, G et al. A new method for assessing drug causation provided agreement with experts’ judgment. J Clin Epidemiol. 2006;59(3):308-314.doi:10.1016/j.jclinepi.2005.08.012 16488362
Google Scholar | Crossref | Medline11. Tricco, AC., Lillie, E., Zarin, W et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-473.doi:10.7326/M18-0850 30178033
Google Scholar | Crossref | Medline12. Daoud, MS., Schanbacher, CF., Dicken, CH. Recognizing cutaneous drug eruptions. Reaction patterns provide clues to causes. Postgrad Med. 1998;104(1):101-105.doi:10.3810/pgm.1998.07.537 9676565
Google Scholar | Crossref | Medline13. Macedo, AF., Marques, FB., Ribeiro, CF., Teixeira, F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf. 2005;14(12):885-890.doi:10.1002/pds.1138 16059869
Google Scholar | Crossref | Medline14. Sasidharanpillai, S., Riyaz, N., Khader, A., Rajan, U., Binitha, MP., Sureshan, DN. Severe cutaneous adverse drug reactions: a clinicoepidemiological study. Indian J Dermatol. 2015;60(1):102 doi:10.4103/0019-5154.147834 25657416
Google Scholar | Crossref | Medline15. Brockow, K., Przybilla, B., Aberer, W et al. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int. 2015;24(3):94-105.doi:10.1007/s40629-015-0052-6
Google Scholar | Crossref | Medline16. Atzori, L., Pinna, AL., Pilloni, L et al. Acute generalized exanthematous pustulosis: the experience of an Italian drug-surveillance centre. G Ital di Dermatologia e Venereol. 2007;142(4):303-310.
Google Scholar17. Davidovici, B, Dodiuk-Gad, R, Rozenman, D, Halevy, S, Israeli RegiSCAR Network. Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR study. Isr Med Assoc J. 2008;10(6):410-412.18669133
Google Scholar | Medline18. Akpinar, F., Dervis, E. Drug eruptions: an 8-year study including 106 inpatients at a dermatology clinic in turkey. Indian J Dermatol. 2012;57(3):194-198.doi:10.4103/0019-5154.96191 22707770
Google Scholar | Crossref | Medline19. Soria, A., Bernier, C., Veyrac, G., Barbaud, A., Puymirat, E., Milpied, B. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study. J Am Acad Dermatol. 2020;82(3):606-611.doi:10.1016/j.jaad.2019.09.036 31562941
Google Scholar | Crossref | Medline20. Scavone, C., Di Mauro, C., Ruggiero, R et al. Severe cutaneous adverse drug reactions associated with allopurinol: an analysis of spontaneous reporting system in southern Italy. Drugs Real World Outcomes. 2020;7(1):41-51.doi:10.1007/s40801-019-00174-7 31848905
Google Scholar | Crossref | Medline21. Kardaun, SH., Sekula, P., Valeyrie-Allanore, L et al. Drug reaction with eosinophilia and systemic symptoms (dress): an original multisystem adverse drug reaction. results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-1080.doi:10.1111/bjd.12501 23855313
Google Scholar | Crossref | Medline22. Zhang, C., Van, DN., Hieu, C., Craig, T. Drug-induced severe cutaneous adverse reactions: determine the cause and prevention. Ann Allergy Asthma Immunol. 2019;123(5):483-487.doi:10.1016/j.anai.2019.08.004 31400461
Google Scholar | Crossref | Medline23. Sidoroff, A., Dunant, A., Viboud, C et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157(5):989-996.doi:10.1111/j.1365-2133.2007.08156.x 17854366
Google Scholar | Crossref | Medline24. Alniemi, DT., Wetter, DA., Bridges, AG et al. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo clinic, 1996-2013. Int J Dermatol. 2017;56(4):405-414.doi:10.1111/ijd.13434 28084022
Google Scholar | Crossref | Medline25. Bastuji-Garin, S., Fouchard, N., Bertocchi, M., Roujeau, JC., Revuz, J., Wolkenstein, P. Scorten: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149-153.doi:10.1046/j.1523-1747.2000.00061.x 10951229
Google Scholar | Crossref | Medline | ISI26. Théophile, H., Arimone, Y., Miremont-Salamé, G et al. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug Saf. 2010;33(11):1045-1054.doi:10.2165/11537780-000000000-00000 20925441
Google Scholar | Crossref | Medline27. Sivanandy, P., Kumaran KoSA, RA. A study on assessment, monitoring and reporting of adverse drug reactions in Indian Hospital. Asian J Pharm Clin Res. 2011;4(3):112-116.
Google Scholar28. Benahmed, S., Picot, MC., Hillaire-Buys, D., Blayac, JP., Dujols, P., Demoly, P. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol. 2005;61(7):537-541.doi:10.1007/s00228-005-0962-1 16021437
Google Scholar | Crossref | Medline29. Chave, TA., Mortimer, NJ., Sladden, MJ., Hall, AP., Hutchinson, PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol. 2005;153(2):241-253.doi:10.1111/j.1365-2133.2005.06721.x 16086734
Google Scholar | Crossref | Medline | ISI30. Zhao, J., Hu, L., Zhang, L., Zhou, M., Gao, L., Cheng, L. Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis. An Bras Dermatol. 2019;94(6):664-670.doi:10.1016/j.abd.2019.01.007 31789251
Google Scholar | Crossref | Medline31. Naranjo, CA., Kwok, MC., Lanctôt, KL., Zhao, HP., Spielberg, SP., Shear, NH. Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach. Clin Pharmacol Ther. 1994;56(5):564-575.doi:10.1038/clpt.1994.178 7955821
Google Scholar | Crossref | Medline32. Salameh, F., Kravitz, MS., Barzilai, A et al. Clinical application of static fluorescence-based cytometry, Cellscan, in cutaneous adverse drug reaction. J Dermatol. 2011;38(5):447-455.doi:10.1111/j.1346-8138.2010.01000.x 21352273
Google Scholar | Crossref | Medline33. Low, YS., Caster, O., Bergvall, T et al. Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson syndrome. J Am Med Inform Assoc. 2016;23(5):968-978.doi:10.1093/jamia/ocv127 26499102
Google Scholar | Crossref | Medline34. Ben Mahmoud, L., Bahloul, N., Ghozzi, H et al. Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs. Therapie. 2017;72(5):539-545.doi:10.1016/j.therap.2017.01.011 28416298
Google Scholar | Crossref | Medline35. Santiago, F., Gonçalo, M., Vieira, R., Coelho, S., Figueiredo, A. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). 62. Contact Dermatitis; 2010:47-53.doi:10.1111/j.1600-0536.2009.01659.x
Google Scholar36. Friedmann, PS., Ardern-Jones, M. Patch testing in drug allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):291-296.doi:10.1097/ACI.0b013e32833aa54d 20485160
Google Scholar | Crossref | Medline37. Barbaud, A . Usefulness of drug patch testing in cutaneous drug allergy: what is new? Rev Fr d’allergologie d’immunologie Clin. 2003;43(4):222-226.doi:10.1016/S0335-7457(03)00099-6
Google Scholar | Crossref

留言 (0)

沒有登入
gif